Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

330 ARTÍCULOS , VIENDO DEL 316 AL 330

Botulinum toxin type A or selective neurotomy for treating focal spastic muscle overactivity?

Deltombe T, Lejeune T, Gustin T.

Ann Phys Rehabil Med. 2019 Jul;62(4):220-224. doi: 10.1016/j.rehab.2018.07.008. Epub 2018 Aug 11.

Effect of continuous intrathecal baclofen therapy in children: a systematic review

Buizer AI, Martens BHM, Grandbois van Ravenhorst C, Schoonmade LJ, Becher JG, Vermeulen RJ.

Dev Med Child Neurol. 2019 Feb;61(2):128-134. doi: 10.1111/dmcn.14005. Epub 2018 Sep 6.

High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapy

Albrecht P, Jansen A, Lee JI, Moll M, Ringelstein M, Rosenthal D, Bigalke H, Aktas O, Hartung HP, Hefter H.

Neurology. 2019 Jan 1;92(1):e48-e54. doi: 10.1212/WNL.0000000000006688. Epub 2018 Nov 21.

The neurophysiology of deforming spastic paresis: A revised taxonomy

Baude M, Nielsen JB, Gracies JM.

Ann Phys Rehabil Med. 2019 Nov;62(6):426-430. doi: 10.1016/j.rehab.2018.10.004. Epub 2018 Nov 28.

Subtle Imaging Findings Aid the Diagnosis of Adolescent Hereditary Spastic Paraplegia and Ataxia

Wagner F, Titelbaum DS, Engisch R, Coskun EK, Waugh JL.

Clin Neuroradiol. 2019 Jun;29(2):215-221. doi: 10.1007/s00062-018-0665-5. Epub 2018 Jan 29.

Complete elimination of a pathogenic homoplasmic mtDNA mutation in one generation

Brady L, Sadikovic B, Rupar CA, Tarnopolsky MA.

Mitochondrion. 2019 Mar;45:18-21. doi: 10.1016/j.mito.2018.01.010. Epub 2018 Feb 1.

Movement disorders in cerebrotendinous xanthomatosis

Stelten BML, van de Warrenburg BPC, Wevers RA, Verrips A.

Parkinsonism Relat Disord. 2019 Jan;58:12-16. doi: 10.1016/j.parkreldis.2018.07.006. Epub 2018 Jul 19.

The glucose transporter type 1 (Glut1) syndromes

Koch H, Weber YG.

Epilepsy Behav. 2019 Feb;91:90-93. doi: 10.1016/j.yebeh.2018.06.010. Epub 2018 Jul 31.

Idiopathic spinal cord herniation: consideration of its pathogenesis based on the histopathology of the dura mater

Shimizu S, Kobayashi Y, Oka H, Kumabe T.

Eur Spine J. 2019 Feb;28(2):298-305. doi: 10.1007/s00586-017-5147-y. Epub 2017 Jun 7.

Intensive Gait Treatment Using a Robot Suit Hybrid Assistive Limb in Acute Spinal Cord Infarction: Report of Two Cases

Watanabe H, Marushima A, Kawamoto H, Kadone H, Ueno T, Shimizu Y, Endo A, Hada Y, Saotome K, Abe T, Yamazaki M, Sankai Y, Ishikawa E, Matsumura A.

J Spinal Cord Med. 2019 May;42(3):395-401. doi: 10.1080/10790268.2017.1372059. Epub 2017 Oct 9.

Non-pharmacological interventions for spasticity in adults: An overview of systematic reviews

Khan F, Amatya B, Bensmail D, Yelnik A.

Ann Phys Rehabil Med. 2019 Jul;62(4):265-273. doi: 10.1016/j.rehab.2017.10.001. Epub 2017 Oct 16.

Amyotrophic lateral sclerosis presenting as the temporomandibular disorder: A case report and literature review

Hwang WJ, Huang K, Huang JS.

Cranio. 2019 May;37(3):196-200. doi: 10.1080/08869634.2017.1407117. Epub 2017 Nov 28.

Pelizaeus-Merzbacher-Like Disease 1

Nahhas N, Conant A, Orthmann-Murphy J, Vanderver A, Hobson G.

2017 Dec 21 [updated 2019 Jan 17]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Transcutaneous electrical nerve stimulation for spasticity: A systematic review

Fernández-Tenorio E, Serrano-Muñoz D, Avendaño-Coy J, Gómez-Soriano J.

Neurologia (Engl Ed). 2019 Sep;34(7):451-460. doi: 10.1016/j.nrl.2016.06.009. Epub 2016 Jul 26.

HTRA1 Disorder

Onodera O, Nozaki H, Fukutake T.

2010 Apr 27 [updated 2019 Nov 7]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias